Showing results (551-560 of 573) with videos related to

Sort By:
Pageof 58
Gynecologic Oncology|January 23, 2024
A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancerMihaela C Cristea, Daphne Stewart, Timothy Synold, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 5, 2017
Effective encapsulation and biological activity of phosphorylated chemotherapeutics in calcium phosphosilicate nanoparticles for the treatment of pancreatic cancerWelley S Loc, Samuel S Linton, Zachary R Wilczynski, et al.
Research Square|March 3, 2023
Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian CancerA W Adamson, Y C Ding, L Steele, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 16, 2021
Preferential uptake of antibody targeted calcium phosphosilicate nanoparticles by metastatic triple negative breast cancer cells in co-cultures of human metastatic breast cancer cells plus bone osteoblastsKaren M Bussard, Christopher M Gigliotti, Bernadette M Adair, et al.
Journal of Ovarian Research|July 17, 2023
Genomic analyses of germline and somatic variation in high-grade serous ovarian cancerA W Adamson, Y C Ding, L Steele, et al.
The Journal of Cell Biology|March 12, 2008
Important role of matrix metalloproteinase 9 in epileptogenesisGrzegorz M Wilczynski, Filip A Konopacki, Ewa Wilczek, et al.
Molecular Cancer Research : MCR|February 11, 2017
Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 ExpressionCanan Kasikara, Sushil Kumar, Stanley Kimani, et al.
Plos One|May 25, 2012
Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosisXiwei Wu, Lihong Weng, Xuejun Li, et al.
NPJ Breast Cancer|July 20, 2017
Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630Ronald K Potkul, Joseph M Unger, Robert B Livingston, et al.
Oncogene|August 8, 2002
Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancerEri S Srivatsan, Rita Chakrabarti, Kayvan Zainabadi, et al.
Pageof 58